Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Carlos Cruz‐Teran, Karthik Tiruthani, Morgan D. McSweeney, Alice Ma, Raymond J. Pickles, Samuel K. Lai
Topics & Concepts
Monoclonal antibodyCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicMedicine2019-20 coronavirus outbreakAntiviral therapyImmunologyAntibodyVirusInfectious disease (medical specialty)Internal medicineOutbreakDiseaseChronic hepatitisSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections researchInhalation and Respiratory Drug Delivery